S
RVMD icon

Sachetta’s Revolution Medicines RVMD Stock Holding History

Sachetta’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06K Buy
+27
New +$3.94K ﹤0.01% 652

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Sachetta's RVMD Position: Q2 2026 in Review

Sachetta opened a new position in Revolution Medicines (RVMD) in Q2 2026: 27 shares worth $5.06K. The stake represents ﹤0.01% of the portfolio and ranks #652 among its holdings.

90 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sachetta held 27 shares of Revolution Medicines worth $5.06K as of Q2 2026.
  • Revolution Medicines was a new Sachetta position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #652 holding.
  • 90 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.